DOCSLIB.ORG

United States Patent (19) 11 4,376,789 Lowicki Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
United States Patent (19) 11 4,376,789 Lowicki Et Al United States Patent (19) 11 4,376,789 Lowicki et al. (45) Mar. 15, 1983 (54) SURFACTANTS WHICH ARE POLYHYDRIC 4,150,041 4/1979 Suzuki et al. .................... 260/346.6 ALCOHOL PARTIAL ESTERS OF ADDUCTS OTHER PUBLICATIONS OF MALE CANHYDRDE WITH AN UNSATURATED CARBOXYLECACID Sastry et al.-J. Amer. Oil Chem. Soc., vol. 48 (1971), pp. 686-688. 75) Inventors: Norbert Lowicki, Duisburg; Rheineck et al.-Fette-Seifen-Anstrichmit, vol. 71 Natvarlal B. Desai, Dinslaken, both (1969), pp. 644-652. of Fed. Rep. of Germany Nagakura-Chem. Abst., vol. 91 (1979), p. 22764h. 73) Assignee: Grillo-Werke AG, Vainer et al.-Chem. Abst., vol. 76 (1972), p. 29524d. Duisburg-Hamborn, Fed. Rep. of Nagakura et al.-Chem. Abst, vol. 83 (1975), p. 27496s. Germany Dow-Chem. Abst., vol. 83 (1975), p. 178328q. Bibby-Chem. Abst., vol. 88 (1978), p. 22149Z. 21 Appl. No.: 240,606 Suzuki-Chem. Abst., vol. 89 (1978), p. 76632r. (22 Filed: Mar. 4, 1981 Asao et al.-Chem. Abst, vol. 84 (1976), p. 91,967u. (30) Foreign Application Priority Data Broniarz et al.-Chem. Abst, vol. 79 (1973), p. 7158x. Primary Examiner-Sam Rosen Aug. 29, 1980 IDE Fed. Rep. of Germany ....... 3032612 Attorney, Agent, or Firm-Merriam, Marshall & Bicknell 51 Int. C. ..................... A61K 47/00; A61K 31/70; CO7H 13/06; C07C 69/74 57 ABSTRACT 52 U.S. C. .................................... 424/361; 424/180; Disclosed are novel polyhydric alcohol partial esters of 424/314; 424/365; 536/119; 560/123; 562/505; polycarboxylic acids from Diels-Alder adducts of ma 252/174.18; 549/245 leic anhydride and a straight chain unsaturated carbox 58) Field of Search ..................... 260/346.6; 536/119; ylic acid having ten to twenty-five carbon atoms. The 424/180, 314, 361; 562/505; 560/123; 252/108, partial esters can be subsequently sulfated. 121, 142, 174.18 The polyhydric alcohol can be a mono- or disaccharide 56) References Cited such as sucrose or mannose. U.S. PATENT DOCUMENTS The partial esters are surfactants which are der matologially acceptable and useful in personal products 2,137,616 11/1938 Hunn ................................ 260/346.6 2,839,550 6/1958 Wiggerink et al. ... 260/346.6 and skin-care products. 3,053,830 9/1962 Gaertner ............................. 536/119 3,219,657 11/1965 Gaertner ............................. 536/119 12 Claims, No Drawings 4,376,789 1. 2 A specially advantageous property of the partial es SURFACTANTS WHICH ARE POLYHYDRC ters of the invention is their compatibility with hard ALCOHOL PARTAL ESTERS OF ADDUCTS OF water, with which they generate no precipitates. MALE CANHYDRDE WITH AN UNSATURATED Another surprising advantage is that the sugar esters CARBOXYLIC ACD 5 of the invention are readily and easily produced on a large scale. According to Industrial Engineering Chem This invention is concerned with partial esters of istry, 48 (1956), pages 1459 to 1464, sugar esters are polyhydric alcohols, especially of mono- and disaccha produced, for example, by ester interchange of fatty rides, with the polycarboxylic acids which result from acid alkyl esters with sugar in dimethyl formamide in the Diels-Alder adducts of maleic anhydride with sim 10 the presence of an alkaline catalyst at about 90° C. The ple unsaturated carboxylic acids having a chain length reaction time amounts to about 12 hours and purifica of C10 to C25 and which, if desired, can be sulfated. tion of the reaction product is difficult, especially as to Further, the invention is concerned with processes of complete removal of the dimethyl formamide. A nearly producing these products, as well as with their use as quantitative recovery of this solvent is important for dermatologically acceptable nonionic and/or anionic 15 economic reasons. On the other hand, dimethyl form surfactants in cosmetic preparations. amide is not physiologically acceptable. Despite careful The Diels-Alder adducts of maleic anhydride with purification of the sugar ester obtained in this manner, simple unsaturated carboxylic acids are known. They for example a sucrose ester, small amounts of the physi can be saponified with alkali, and their esters and am ologically objectionable dimethyl formamide remain in ides, especially their reaction products with triethanol 20 the end product and which, furthermore, cause a dis amine, are useful as anticorrosives; cf. U.S. Pat. No. agreeable odor. 3,985,504. The alkali salts have already been used to According to German published patent application prevent formation of deposits from hot seawater; cf. No. AS 2022 880 the ester interchange of fatty acid Great Britain Pat. No. 1,551,894. esters with sucrose can occur through addition of 1 to The chemical structure of the adducts is not fully 25 40% by weight of an alkali-free alkali salt or soap of explained, since statements in the two above-mentioned saturated and unsaturated fatty acids, as a catalyst. The patents are contradictory. According to U.S. Pat. No. ester interchange is carried out at 160 to 190 C, within 3,985,504 an addition of carbon atoms takes place next 20 minutes. After termination of the reaction, the re to the double bond, with the double bond remaining maining mixture is rapidly cooled and the unreacted preserved. According to Great Britain Pat. No. 30 sucrose, as well as the soap used as a catalyst, are re 1,551,894 cyclobutanedicarboxylic acids are obtained. moved. Although the process operates without sol In any case, through hydrolysis of the adducts, tri- and vents, the cost of preparing the alkali soap is very high. poly-carboxylic acids are obtained. To prepare alkali-free soap, the alkali metal hydroxides It has now been found that polyhydric alcohol partial are first dissolved in aqueous methanol under nitrogen esters, especially of mono- and disaccharides, with poly 35 by heating at a reflux temperature. Afterwards, the carboxylic acids which result from a Diels-Alder ad methyl ester of the selected long-chain fatty acid is duct of maleic anhydride with at least one unsaturated added and the mixture is heated for 40 to 60 minutes carboxylic acid having a chain length of C10 to C25, under reflux. The methanol is then vacuum distilled possess unusual and extremely valuable properties. The from the soap formed in the process. unsaturated carboxylic acid desirably has a straight 40 A further disadvantage of the described process is carbon chain. It has been found that these partial esters that yields of the sucrose ester amount to only about 43 are excellent dermatologically acceptable nonionic sur to 48%. This is because it is difficult to control the high factants especially suitable for use in cosmetic prepara reaction temperatures so as to prevent disintegration of tions. Surprisingly, these partial esters can be sulfated reactants, and the product, from occurring. under gentle conditions, with the double bond of the 45 According to German published patent application unsaturated carboxylic acids remaining unaltered as No. AS 24 12 374, sucrose can be ester-interchanged shown, for example, by the iodine number of the prod with a triglyceride at 100 to 170° C. with use of alkaline ucts. The sulfated partial esters likewise form extremely catalysts. The yield of sucrose esters after 10 to 22 hours useful dermatologically acceptable anionic surfactants of reaction time is between 11 and 40%. Solid products which are likewise especially suitable in cosmetic prep 50 are produced which are insoluble in water, or which are arations. soluble only with great difficulty in water, and which The sulfated partial esters of mono- and disaccharides react with the mineral content of the water. are the first sulfated sugar esters and they are especially The process according to German published patent useful in producing mild cleansers and dermatologically application No. AS 24 12374 cannot be applied to the acceptable detergents. 55 production of unsaturated fatty acids since the long The sulfation can be carried out in such mild condi reaction times lead to formation of resinous products tions, namely at temperatures below 100 C., with so with insufficient dispersibility in oil. Finally, working dium sulfite, that the process is not by any means com up of the sucrose esters produced in low yield is very parable to the usual sulfation of olefins. It is believed, expensive. therefore, that in the sulfation of the products of the 60 According to the invention, partial esters of polyhyd invention, a substitution takes place on an activated ric alcohols, particularly mono- and disaccharides, in carbon atom of the maleic acid molecule. The partial cluding partial esters of mannose, glucose and the very esters of mono- and disaccharides, according to the sensitive sucrose, can be produced at 85 to 90 C. invention, provide a completely new type of sugar ester within a reaction time of 1 to 5 hours by reaction with and sugar-based surfactant, which by reason of their 65 the adduct or a polycarboxylic acid formed by hydroly favorable toxicological and dermatological properties, sis of the adduct. The partial ester products thus ob are clearly superior to most, if not all, products hitherto tained are completely water soluble and provide, from known. the outset, excellent compatibility with the skin and 4,376,789 3 4. mucous membranes. In the process of the invention, the ylic acid which then desirably is esterified with ethylene reaction is carried out without solvents. In addition, glycol. Thereafter, these partial esters can be subjected about 5 to 10% by weight of an alkaline material, for to ester interchange with the polyhydric alcohol. In this example sodium hydroxide, potassium carbonate or manner, especially pure and very compatible partial trisodium phosphate, can be used as the catalyst. Surpis ester products are obtained which are produced under ingly, as the reaction progresses, the viscosity of the the most gentle conditions.
Load more

Recommended publications
  • Retention Indices for Frequently Reported Compounds of Plant Essential Oils
    Retention Indices for Frequently Reported Compounds of Plant Essential Oils V. I. Babushok,a) P. J. Linstrom, and I. G. Zenkevichb) National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA (Received 1 August 2011; accepted 27 September 2011; published online 29 November 2011) Gas chromatographic retention indices were evaluated for 505 frequently reported plant essential oil components using a large retention index database. Retention data are presented for three types of commonly used stationary phases: dimethyl silicone (nonpolar), dimethyl sili- cone with 5% phenyl groups (slightly polar), and polyethylene glycol (polar) stationary phases. The evaluations are based on the treatment of multiple measurements with the number of data records ranging from about 5 to 800 per compound. Data analysis was limited to temperature programmed conditions. The data reported include the average and median values of retention index with standard deviations and confidence intervals. VC 2011 by the U.S. Secretary of Commerce on behalf of the United States. All rights reserved. [doi:10.1063/1.3653552] Key words: essential oils; gas chromatography; Kova´ts indices; linear indices; retention indices; identification; flavor; olfaction. CONTENTS 1. Introduction The practical applications of plant essential oils are very 1. Introduction................................ 1 diverse. They are used for the production of food, drugs, per- fumes, aromatherapy, and many other applications.1–4 The 2. Retention Indices ........................... 2 need for identification of essential oil components ranges 3. Retention Data Presentation and Discussion . 2 from product quality control to basic research. The identifi- 4. Summary.................................. 45 cation of unknown compounds remains a complex problem, in spite of great progress made in analytical techniques over 5.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,375.433 B2 Dilly Et Al
    US009375433B2 (12) United States Patent (10) Patent No.: US 9,375.433 B2 Dilly et al. (45) Date of Patent: *Jun. 28, 2016 (54) MODULATORS OF ANDROGENSYNTHESIS (52) U.S. Cl. CPC ............. A6 IK3I/519 (2013.01); A61 K3I/201 (71) Applicant: Tangent Reprofiling Limited, London (2013.01); A61 K3I/202 (2013.01); A61 K (GB) 31/454 (2013.01); A61K 45/06 (2013.01) (72) Inventors: Suzanne Dilly, Oxfordshire (GB); (58) Field of Classification Search Gregory Stoloff, London (GB); Paul USPC .................................. 514/258,378,379, 560 Taylor, London (GB) See application file for complete search history. (73) Assignee: Tangent Reprofiling Limited, London (56) References Cited (GB) U.S. PATENT DOCUMENTS (*) Notice: Subject to any disclaimer, the term of this 5,364,866 A * 1 1/1994 Strupczewski.......... CO7C 45/45 patent is extended or adjusted under 35 514,254.04 U.S.C. 154(b) by 0 days. 5,494.908 A * 2/1996 O’Malley ............. CO7D 261/20 514,228.2 This patent is Subject to a terminal dis 5,776,963 A * 7/1998 Strupczewski.......... CO7C 45/45 claimer. 514,217 6,977.271 B1* 12/2005 Ip ........................... A61K 31, 20 (21) Appl. No.: 14/708,052 514,560 OTHER PUBLICATIONS (22) Filed: May 8, 2015 Calabresi and Chabner (Goodman & Gilman's The Pharmacological (65) Prior Publication Data Basis of Therapeutics, 10th ed., 2001).* US 2015/O238491 A1 Aug. 27, 2015 (Cecil's Textbook of Medicine pp. 1060-1074 published 2000).* Stedman's Medical Dictionary (21st Edition, Published 2000).* Okamoto et al (Journal of Pain and Symptom Management vol.
    [Show full text]
  • Fatty Acids As Essential Adjuvants to Treat Various Ailments and Their Role in Drug Delivery: a Review
    Nutrition 65 (2019) 138À157 Contents lists available at ScienceDirect Nutrition journal homepage: www.nutritionjrnl.com Review article Fatty acids as essential adjuvants to treat various ailments and their role in drug delivery: A review Aakash Katdare B. Pharm, MS. Pharm, Shreya Thakkar B. Pharm, M. Pharm, Shivshankar Dhepale B. Pharm, MS. Pharm, Dignesh Khunt B. Pharm, M. Pharm, Manju Misra B. Pharm, M. Pharm, Ph.D. * Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Ahmedabad, India ARTICLE INFO ABSTRACT Article History: Since the discovery of fatty acids, a niche has been carved for their vital role as adjuvants in drug delivery and Received 23 May 2018 as treatment for various diseases. The literature has repeatedly described the essential role of various fatty Received in revised form 1 February 2019 acids in treating a wide range of diseases and disorders, from central nervous system diseases to wound heal- Accepted 20 March 2019 ing. The use of fatty acids has expanded to many horizons and in recent decades they have gained impor- tance as drug delivery adjuvants in addition to their auxiliary benefits in treating various diseases. Although Keywords: fatty acids aid in solving both formulation-based and therapeutic challenges to our knowledge, they have Polyunsaturated FA never been viewed as dual agents in modern scientific literature. The aim of this review was to provide this FA Lipids perspective and combine the very discreet literature about fatty acids, which includes their role as therapeu- Oils tic adjuvants and drug delivery agents. It gives insights on the use of fatty acids in treating the diseases of the Penetration enhancers eye, skin, central nervous system, viral diseases, and so on.
    [Show full text]
  • Biochemistry Prologue to Lipids
    Paper : 05 Metabolism of Lipids Module: 01 Prologue to Lipids Principal Investigator Dr. Sunil Kumar Khare, Professor, Department of Chemistry, IIT-Delhi Paper Coordinator and Dr. Suaib Luqman, Scientist (CSIR-CIMAP) Content Writer & Assistant Professor (AcSIR) CSIRDr. Vijaya-CIMAP, Khader Lucknow Dr. MC Varadaraj Content Reviewer Prof. Prashant Mishra, Professor, Department of Biochemical Engineering and Biotechnology, IIT-Delhi 1 METABOLISM OF LIPIDS Biochemistry Prologue to Lipids DESCRIPTION OF MODULE Subject Name Biochemistry Paper Name 05 Metabolism of Lipids Module Name/Title 01 Prologue to Lipids 2 METABOLISM OF LIPIDS Biochemistry Prologue to Lipids 1. Objectives To understand what is lipid Why they are important How they occur in nature 2. Concept Map LIPIDS Fatty Acids Glycerol 3. Description 3.1 Prologue to Lipids In 1943, the term lipid was first used by BLOOR, a German biochemist. Lipids are heterogeneous group of compounds present in plants and animal tissues related either actually or potentially to the fatty acids. They are amphipathic molecules, hydrophobic in nature originated utterly or in part by thioesters (carbanion-based condensations of fatty acids and/or polyketides etc) or by isoprene units (carbocation-based condensations of prenols, sterols, etc). Lipids have the universal property of being: i. Quite insoluble in water (polar solvent) ii. Soluble in benzene, chloroform, ether (non-polar solvent) 3 METABOLISM OF LIPIDS Biochemistry Prologue to Lipids Thus, lipids include oils, fats, waxes, steroids, vitamins (A, D, E and K) and related compounds, such as phospholipids, triglycerides, diglycerides, monoglycerides and others, which are allied more by their physical properties than by their chemical assests.
    [Show full text]
  • Measurement of Attenuation Cross-Sections of Some Fatty Acids in the Energy Range 122–1330 Kev
    Pramana – J. Phys. (2016) 87: 12 c Indian Academy of Sciences DOI 10.1007/s12043-016-1213-y Measurement of attenuation cross-sections of some fatty acids in the energy range 122–1330 keV D K GAIKWAD1,∗,PPPAWAR1 and T P SELVAM2 1Department of Physics, Dr Babasaheb Ambedkar Marathwada University, Aurangabad 431 004, India 2Radiation Physics and Advisory Division, BARC, Anushaktinagar, Mumbai 400 085, India ∗Corresponding author. E-mail: [email protected] MS received 14 June 2015; revised 7 August 2015; accepted 7 September 2015; published online 18 June 2016 Abstract. The mass attenuation coefficients (μm) have been measured for undecylic acid (C11H22O2), lau- ric acid (C12H24O2), tridecylic acid (C13H26O2), myristic acid (C14H28O2), pentadecylic acid (C15H30O2)and 57 133 137 60 22 palmitic acid (C16H32O2)using Co, Ba, Cs, Co and Na emitted γ radiation with energies 122, 356, 511, 662, 1170, 1275 and 1330 keV, respectively. The accurate values of the effective atomic number (Zeff), atomic cross-section (σt,), electronic cross-section (σe) and the effective electron density (Neff) have great signifi- cance in radiation protection and dosimetry. These quantities were obtained by utilizing experimentally measured values of mass attenuation coefficients (μm). A NaI(Tl) scintillation detector with 8.2% (at 662 keV) resolu- tion was used for detecting of attenuated γ -photons. The variation in Zeff and Neff of fatty acids with energy is discussed. The experimental and theoretical results are in good agreement within 2% deviation. Keywords. Fatty acids; NaI(Tl) scintillation detector; Zeff and Neff. PACS Nos 32.80.−t; 32.90.+a; 32.80.Fb; 20; 33.80.−b 1.
    [Show full text]
  • Environmental Alterations in Biofuel Generating Molecules in Zilla Spinosa
    Z. Naturforsch. 2017; 72(3-4)c: 77–91 Hemmat Khattab* and Zeinab El Marid Environmental alterations in biofuel generating molecules in Zilla spinosa DOI 10.1515/znc-2016-0151 acclimatization of Z. spinosa plants to soil water scarcity Received February 1, 2016; revised September 1, 2016; accepted associated with heat stress experienced during summer. September 4, 2016 In addition, the alterations in the fatty acid profiles may match biofuel requirements. In conclusion, the most ade- Abstract: Now days, production of fuels and petrochemi- quate growing season (spring) will be decisive for achiev- cals from renewable lignocellulosic biomass is an indis- ing high lipid productivity associated with improved pensable issue to meet the growing energy demand. biofuel quality in terms of high saturated fatty acids per- Meanwhile, the changes in the climate and soil topogra- centage that improves its cetane number. However, the phy influence the growth and development as well as can- dry summer season enhanced the accumulation of greater opy level of the lignocellulosic biomass. In this study, Zilla amount of lignin that may enhance the biodiesel quantity. spinosa Turr (Zilla) plants with similar age and size were collected from three main sectors (upstream, midstream, Keywords: biofuel; carbohydrates; cellulose; fatty acids; and downstream) of Wadi Hagul during spring (April) and heat stress; lignin; lipids; water scarcity; Zilla spinose summer (July) seasons. Environmental stresses evoked (Turr). reduction in the energy trapping pigments concomitant with increments in chlorophyll fluorescence in summer harvested plants particularly at downstream. Further- more, the biofuels generating compounds including car- 1 Introduction bohydrate, lignin, and lipid making the plant biomasses The Bio-energy from natural photosynthetic biomass can are greatly affected by environmental conditions.
    [Show full text]
  • NON-CLINICAL REVIEW(S) DEPARTMENT of HEALTH & HUMAN SERVICES Food and Drug Administration
    CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 206089Orig1s000 NON-CLINICAL REVIEW(S) DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration PHARMACOLOGY/TOXICOLOGY MEMORANDUM CDER Stamp Date: September 27, 2018 NDA: 206089 Sponsor: Clarus Therapeutics, Inc. Drug: Testosterone undecanoate (JATENZO) Replacement therapy in adult males for conditions associated Indication: with a deficiency or absence of endogenous testosterone due to primary or hypogonadotropic hypogonadism Subject: Final Labeling Review Reviewer: Yangmee Shin, PhD Background: Clarus Therapeutics resubmitted NDA 206089 under a 505(b)(2) regulatory pathway following a 2nd Complete Response (CR) letter issued on March 22, 2018. NDA 206089 was first submitted on January 3, 2014 as a 505(b)(2) application. To support the nonclinical requirements of NDA via a 505(b)(2) pathway, the sponsor submitted published literature along with the findings of a 3-month oral toxicology study of Clarus’ oral testosterone undecanoate (TU) formulation in dogs. The sponsor also provided literature references to address ADME of TU by the oral route. The 3-month oral toxicology study in male dogs and relevant published literature were provided to support the use of borage oil as a novel excipient. The sponsor also supplied published literature regarding the fertility, pregnancy, and carcinogenicity of testosterone (T). Pharmacology and Toxicology recommended approval of the initial submission of NDA 206089 during the first cycle review. In the 1st resubmission to NDA 206089 on June 22, 2017, Clarus refiled the NDA as a 505(b)(1) application and provided nonclinical studies of oral TU including a 9-month oral toxicology study in male dogs, a battery of genotoxicity tests, a 6-month carcinogenicity study in Tg·rasH2 male mice, and a fertility study in male rats, upon agreement with the Division on November 19, 2015.
    [Show full text]
  • Fatty Acids, Trivial and Systematic Names
    FATTY ACIDS, TRIVIAL AND SYSTEMATIC NAMES Trivial Name Systematic Name Abbreviation Formic Acid Methanoic Acid Acetic Acid Ethanoic Acid Propionic Acid Propanoic Acid Butyric Acid Butanoic Acid 4:0 Valerianic Acid Pentanoic Acid 5:0 Caproic Acid Hexanoic Acid 6:0 Enanthic Acid Heptanoic Acid 7:0 Caprylic Acid Octanoic Acid 8:0 Pelargonic Acid Nonanoic Acid 9:0 Capric Acid Decanoic Acid 10:0 Obtusilic Acid 4-Decenoic Acid 10:1(n-6) Caproleic Acid 9-Decenoic Acid 10:1(n-1) Undecylic Acid Undecanoic Acid 11:0 Lauric Acid Dodecanoic Acid 12:0 Linderic Acid 4-Dodecenoic Acid 12:1(n-8) Denticetic Acid 5-Dodecenoic Acid 12:1(n-7) Lauroleic Acid 9-Dodecenoic Acid 12:1(n-3) Tridecylic Acid Tridecanoic Acid 13:0 Myristic Acid Tetradecanoic Acid 14:0 Tsuzuic Acid 4-Tetradecenoic Acid 14:1(n-10) Physeteric Acid 5-Tetradecenoic Acid 14:1(n-9) Myristoleic Acid 9-Tetradecenoic Acid 14:1(n-5) Pentadecylic Acid Pentadecanoic Acid 15:0 Palmitic Acid Hexadecanoic Acid 16:0 Gaidic acid 2-Hexadecenoic Acid 16:1(n-14) Sapienic Acid 6-Hexadecenoic Acid 16:1(n-10) Hypogeic Acid trans-7-Hexadecenoic Acid t16:1(n-9) cis-Hypogeic Acid 7-Hexadecenoic Acid 16:1(n-9) Palmitoleic Acid 9-Hexadecenoic Acid 16:1(n-7) Palmitelaidic Acid trans-9-Hexadecenoic Acid t16:1(n-7) Palmitvaccenic Acid 11-Hexadecenoic Acid 16:1(n-5) Margaric Acid Heptadecanoic Acid 17:0 Civetic Acid 8-Heptadecenoic Acid 17:1 Stearic Acid Octadecanoic Acid 18:0 Petroselinic Acid 6-Octadecenoic Acid 18:1(n-12) Oleic Acid 9-Octadecenoic Acid 18:1(n-9) Elaidic Acid trans-9-Octadecenoic acid t18:1(n-9)
    [Show full text]
  • Man Hon. Tsang Oakland, CA (US); E E SE, 9
    USOO81831 89B2 (12) United States Patent (10) Patent No.: US 8,183,189 B2 Chen et al. (45) Date of Patent: May 22, 2012 (54) PREPARATION OF A SULFURIZED 3,509,051 A 4, 1970 Farmer et al. MOLYBDENUMAMIDE COMPLEX AND 4,098,705. A 7/1978 Sakurai et al. 4,259,194 A 3, 1981 deVries et al. ADDITIVE COMPOSITIONS HAVINGLOW 4,259,195 A 3/1981 King et al. RESIDUAL ACTIVE SULFUR 4.261,843 A 4/1981 King et al. 4,263,152 A 4, 1981 King et al. (75) Inventors: Quinlai Chen, Walnut Creek, CA (US); 4,289,635 A 9, 1981 Schroeck Man Hon. Tsang Oakland, CA (US); E E SE,9 a. Gaurav Bhalla, Hercules, CA (US); 6,174,842 B1 1/2001 Gatto 5. William R. Ruhe, Jr., Benicia, CA (US) 6,358,894 B1 3/2002 Leta et al. 6,509,303 B1 1/2003 Gatto (73) Assignee: Chevron Oronite Company LLC, San 6,914,037 B2 7/2005 Gatto Ramon, CA (US) 2002fOO38.5256,962,896 A1B2 11/20054/2002 Ruhe,Callis etJr. al.et al. (*) Notice: Subject to any disclaimer, the term of this 38885, A. ck 239, Athlet al. ............. 508,198 patent is extended or adjusted under 35 2005/0209111 A1* 9, 2005 Ruhe et al. .................... 508/242 U.S.C. 154(b) by 191 days. OTHER PUBLICATIONS (21) Appl. No.: 12/570,974 PCT International Search Report PCT/US2009/059083 Date of mailing Jun. 18, 2010. (22) Filed: Sep. 30, 2009 * cited by examiner (65)65 PriorO PublicationDO Dat Primary Examiner – Walter D Griffin US 2011 FOOT718O A1 Mar.
    [Show full text]
  • CXXVI.-Y%C Fiycld)~-Omicles of Undecylenic Acid
    View Article Online / Journal Homepage / Table of Contents for this issue THE IIY DROBROMIDES OF UNDECYLENIC ACID. 1191 CXXVI.-Y%c fIycld)~-omiclesof Undecylenic Acid. By JAMES WALKERand JOHNs. LUMSDEN. BRUNNER(Bey-., 1886, 18, 2226), by the addition of hydrogen bromide to undecylenic acid, CI,H,,02, obtained a bromundecylic acid, C,,H,,O,Br, which fused at 35’. No details of the mode of preparation or purification are given. The same acid is mentioned by Nordlinger (Ber., 1890, 23, 2357), but again no details are given. Nardlinger also, by the addition of hydrogen bromide to the methyl and ethyl esters of undecylenic acid, prepared the corresponding esters of a bromundecylic acid, As it has been proved with practical certainty that ufidecylenic acid has the formula CH,:CH*[CH,],*CO,H, compounds obtained from it by the addition of hydrogen bromide must have one or other of the formula : CH,Br*CH,*[CH,],*CO,H and CH,*C€€Br*[CH,~,*CO2H. Nordlinger, on the strength of the rule that the halogen atom in such additions generally takes up the position more remote from the Published on 01 January 1901. Downloaded by Fudan University 23/11/2017 08:36:04. carboxyl group, assumes that Brunner’s acid has the formula CH,Br*[CH,]9*C0,H and that the esters which he himself prepared are the esters of this acid. Since these esters have been made the starting point for determining the constitution of various substances, it is plainly of importance to know if Nordlinger’s assumptions are justified, In the present paper, it is shown that the acid CH,Br*[CH,],*CO,H is not Brunner’s acid, which has in all probability the other con- stitution, C?H,*CHBr*[CH,],*CO,H.
    [Show full text]
  • A Review of Medium-Chain Fatty Acid Production
    processes Review Fermentation of Organic Residues to Beneficial Chemicals: A Review of Medium-Chain Fatty Acid Production Panagiota Stamatopoulou , Juliet Malkowski, Leandro Conrado, Kennedy Brown and Matthew Scarborough * Department of Civil and Environmental Engineering, University of Vermont, Burlington, VT 05405, USA; [email protected] (P.S.); [email protected] (J.M.); [email protected] (L.C.); [email protected] (K.B.) * Correspondence: [email protected] and [email protected] Received: 14 October 2020; Accepted: 23 November 2020; Published: 28 November 2020 Abstract: Medium-chain fatty acids (MCFAs) have a variety of uses in the production of industrial chemicals, food, and personal care products. These compounds are often produced through palm refining, but recent work has demonstrated that MCFAs can also be produced through the fermentation of complex organic substrates, including organic waste streams. While “chain elongation” offers a renewable platform for producing MCFAs, there are several limitations that need to be addressed before full-scale implementation becomes widespread. Here, we review the history of work on MCFA production by both pure and mixed cultures of fermenting organisms, and the unique metabolic features that lead to MCFA production. We also offer approaches to address the remaining challenges and increase MCFA production from renewable feedstocks. Keywords: chain elongation; carboxylate platform; medium-chain fatty acids; carboxylic acids; mixed culture fermentation 1. Introduction Microbial fermentation processes play an important role in food production, nutrient cycling, and pollution remediation. For more than 9000 years, humans have relied on microbial fermentation to produce and protect food [1], and fermentation processes have been used to convert wastes into valuable products since at least the 13th century [2].
    [Show full text]
  • United States Patent (19) 11 4,277,468 Hofmeister Et Al
    United States Patent (19) 11 4,277,468 Hofmeister et al. 45 Jul. 7, 1981 (54) 11-METHYLENESTEROIDS, THEIR 56) References Cited PREPARATION AND PHARMACEUTICAL U.S. PATENT DOCUMENTS PREPARATIONS CONTAINING THEM 3,927,046 12/1975 van den Broek ................ 260/.397.45 (75) Inventors: Helmut Hofmeister; Rudolf Wiechert; OTHER PUBLICATIONS Klaus Annen; Henry Laurent; Fried et al., JACS 83 (1961), pp. 4663-4464. Hermann Steinbeck, all of Berlin, Fed. Rep. of Germany Primary Examiner-Elbert L. Roberts Attorney, Agent, or Firm-Millen & White 73) Assignee: Schering Aktiengesellschaft, Berlin 57 ABSTRACT and Bergkamen, Fed. Rep. of 11-Methylene steroids of Formula I Germany OR 21 Appl. No.: 135,066 H2Cs Sesno CECC 22 Filed: Mar. 28, 1980 (30) Foreign Application Priority Data x1a Mar. 30, 1979 DE Fed. Rep. of Germany ....... 291.338 wherein m (51) Int. Cl. ................................................ CO7 1/OO R is hydrogen or acyl, and 52 U.S. C. ............................... 424/243; 260/397.45; X is oxygen or two hydrogen atoms 260/.397.5 have valuable pharmacological properties. 58) Field of Search ............. 260/.397.4, 397.45, 397.5; 424/243 10 Claims, No Drawings 4,277,468 2 acid, isonicotinic acid, furan-2-carboxylic acid, O 11-METHYLENE STEROIDS, THEIR tridecanoylglycolic acid, O-hexadecanoylglycolic acid, PREPARATION AND PHARMACEUTICAL g-tridecanoyloxypropionic acid, etc. Suitable sulfonic PREPARATIONS CONTAINING THEM acids include: methane-, ethane-, 3-chloroethane-, pro pane-, isopropane-, butane-, cyclopentane-, cyclohex BACKGROUND OF THE INVENTION ane-, benzene-, p-toluene- and p-chlorobenzenesulfonic The present invention relates to 11-methylene ste acids, etc.; and, furthermore, N,N-dimethyl-, N,N- roids, a process for their preparation, and pharmaceuti diethyl, bis(3-chloroethyl)-aminosulfonic acids, etc.; or cal preparations containing them.
    [Show full text]